Si Huang

1.3k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Si Huang is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Si Huang has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Biomedical Engineering and 4 papers in Biomaterials. Recurrent topics in Si Huang's work include Extracellular vesicles in disease (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Si Huang is often cited by papers focused on Extracellular vesicles in disease (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Si Huang collaborates with scholars based in China, United States and Switzerland. Si Huang's co-authors include Daxiong Xiang, Junyong Wu, Yongjiang Li, Xiong-Bin Hu, Wenjie Xu, Shilin Luo, Xiaohan Qiu, Jihua Liu, Xiaojie Zhang and Xinyan Hao and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and Advanced Functional Materials.

In The Last Decade

Si Huang

28 papers receiving 998 citations

Hit Papers

Artificial exosomes for t... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Si Huang China 15 687 255 238 114 112 29 1.0k
Xue Feng China 21 644 0.9× 127 0.5× 219 0.9× 93 0.8× 58 0.5× 50 1.2k
Rui Guo China 18 632 0.9× 291 1.1× 122 0.5× 168 1.5× 92 0.8× 68 1.2k
Xiaomin Su China 23 512 0.7× 333 1.3× 482 2.0× 126 1.1× 67 0.6× 61 1.3k
Mengting Liu China 19 936 1.4× 149 0.6× 287 1.2× 89 0.8× 102 0.9× 33 1.3k
Ke Wei China 20 601 0.9× 149 0.6× 135 0.6× 74 0.6× 182 1.6× 43 1.2k
Johannes F. W. Greiner Germany 19 525 0.8× 246 1.0× 130 0.5× 130 1.1× 44 0.4× 46 1.1k
Harry C. Ledebur United States 12 391 0.6× 174 0.7× 122 0.5× 306 2.7× 121 1.1× 16 990
Olga Zabirnyk United States 9 503 0.7× 232 0.9× 110 0.5× 83 0.7× 60 0.5× 9 1.0k
Xuelian Wang China 19 700 1.0× 194 0.8× 66 0.3× 120 1.1× 57 0.5× 54 1.1k

Countries citing papers authored by Si Huang

Since Specialization
Citations

This map shows the geographic impact of Si Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si Huang more than expected).

Fields of papers citing papers by Si Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Si Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si Huang. The network helps show where Si Huang may publish in the future.

Co-authorship network of co-authors of Si Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Si Huang. A scholar is included among the top collaborators of Si Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si Huang. Si Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Si, Bowen Liu, Fei Peng, et al.. (2025). Micro/Nanomotors Actively Penetrate Physiological Barriers: Basic Nanoarchitectonics to Practical Application. Advanced Materials. 38(6). e08865–e08865.
3.
Zhang, Chenyu, Miao Dai, Jun Yang, et al.. (2025). Patient with HR-proficient advanced ovarian cancer achieved a complete response with Cadonilimab combined chemotherapy (PD-1/CTLA-4 bispecific): a case report and literature review. Gynecologic Oncology Reports. 60. 101785–101785. 1 indexed citations
5.
Wang, Mingming, Chunlei Tan, Si Huang, et al.. (2024). Regulation of Cecal Microbiota and Improvement of Blood Lipids Using Walnut Non-Dairy Creamer in High-Fat Mice: Replacing Traditional Non-Dairy Creamer. Molecules. 29(18). 4469–4469. 1 indexed citations
6.
Zhang, Feng, Mingming Wang, Chunlei Tan, et al.. (2024). Structural characteristics and nonvolatile metabolites of theabrownins and their impact on intestinal microbiota in high-fat-diet-fed mice. Food Chemistry. 463(Pt 3). 141317–141317. 4 indexed citations
7.
Huang, Si, Yongjiang Li, Junyong Wu, et al.. (2024). Biomimetic nanodecoys deliver cholesterol-modified heteroduplex oligonucleotide to target dopaminergic neurons for the treatment of Parkinson's disease. Acta Biomaterialia. 177. 316–331. 6 indexed citations
8.
Zhou, Min, Yucheng Tang, Wenjie Xu, et al.. (2023). Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies. Frontiers in Immunology. 14. 1140463–1140463. 36 indexed citations
9.
Li, Yongjiang, Junyong Wu, Xiaohan Qiu, et al.. (2022). Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy. Bioactive Materials. 20. 548–560. 67 indexed citations
10.
Huang, Si, Xiaoli Liao, Junyong Wu, et al.. (2022). The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia. FEBS Letters. 596(8). 1059–1071. 26 indexed citations
11.
Huang, Si, Xinyan Hao, Yongjiang Li, et al.. (2022). Nonviral delivery systems for antisense oligonucleotide therapeutics. Biomaterials Research. 26(1). 49–49. 35 indexed citations
12.
Huang, Si, et al.. (2022). Tizoxanide Promotes Apoptosis in Glioblastoma by Inhibiting CDK1 Activity. Frontiers in Pharmacology. 13. 895573–895573. 11 indexed citations
13.
Wu, Junyong, Yongjiang Li, Xiong-Bin Hu, et al.. (2021). Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison. Journal of Controlled Release. 336. 510–521. 67 indexed citations
14.
Wu, Junyong, Yongjiang Li, Jiemin Wang, et al.. (2021). Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona. Journal of Nanobiotechnology. 19(1). 405–405. 53 indexed citations
15.
Wu, Junyong, Yongjiang Li, Xiong-Bin Hu, Si Huang, & Daxiong Xiang. (2021). Preservation of small extracellular vesicles for functional analysis and therapeutic applications: a comparative evaluation of storage conditions. Drug Delivery. 28(1). 162–170. 115 indexed citations
16.
Huang, Si, Wenqun Li, Xinyi Liu, et al.. (2021). Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways. Oxidative Medicine and Cellular Longevity. 2021(1). 8843899–8843899. 38 indexed citations
17.
Huang, Si, Qing Wu, Hua Ling, et al.. (2019). Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids. Journal of Ethnopharmacology. 241. 111976–111976. 47 indexed citations
18.
Zhao, Guoping, et al.. (2016). Synergistic Effect of Ferulic Acid and Z‐Ligustilide, Major Components of A. sinensis, on Regulating Cold‐Sensing Protein TRPM8 and TPRA1 In Vitro. Evidence-based Complementary and Alternative Medicine. 2016(1). 3160247–3160247. 10 indexed citations
19.
Huang, Juan, Wei Lü, Shan Sun, et al.. (2014). Upregulation and lysosomal degradation of AQP4 in rat brains with bacterial meningitis. Neuroscience Letters. 566. 156–161. 10 indexed citations
20.
Huang, Juan, Shan Sun, Wei Lu, et al.. (2013). The internalization and lysosomal degradation of brain AQP4 after ischemic injury. Brain Research. 1539. 61–72. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026